The "Malaria P. Vivax Quantitative Test" is a specialized diagnostic procedure designed to detect and measure the presence of Plasmodium vivax, one of the parasites responsible for malaria. This test is particularly important in regions where P. vivax is prevalent, as this species can cause relapses by remaining dormant in the liver for months or even years. The quantitative aspect of the test provides vital information on the parasite load, which is crucial for assessing the severity of the infection and tailoring the treatment plan accordingly.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic techniques and accurate results, the test ensures that individuals receive the most reliable information regarding their malaria status. The cost of the Malaria P. Vivax Quantitative Test is 1020 AED, reflecting the sophisticated nature of the testing process and the invaluable insights it provides into the patient's health status. This test is an essential tool in the fight against malaria, aiding in the prompt and effective treatment of the disease, thereby reducing its health impact on affected populations.
The Extractable Nuclear Antigens (ENA) Anti-Nuclear Antibodies (ANA) Qualitative Profile Test is a comprehensive diagnostic tool used to detect autoimmune disorders. This test specifically looks for the presence of autoantibodies that target the body's own tissues, focusing on the antibodies directed against extractable nuclear antigens. These antigens are proteins found in the nucleus of a cell and are commonly associated with various autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren's syndrome, scleroderma, and mixed connective tissue disease.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques and accuracy, the test involves analyzing a blood sample to identify the presence and type of ANA in the patient's blood. It's a crucial step in diagnosing autoimmune disorders, helping healthcare providers develop an appropriate treatment plan based on the specific antibodies found.
The cost of the ENA ANA Qualitative Profile Test at DNA Labs UAE is 1100 AED. This investment in health can provide critical insights into the patient's condition, guiding both diagnosis and management of autoimmune diseases. It's important for patients undergoing this test to consult with their healthcare provider for a comprehensive understanding of the results and their implications on health management.
The Factor X Functional Test is a crucial diagnostic procedure aimed at measuring the activity of Factor X, a vital component of the coagulation system in the blood. This test is essential for diagnosing and managing conditions related to blood clotting disorders, including Factor X deficiency, which can lead to excessive bleeding or clotting issues. Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test ensures accuracy and reliability in results. The cost of the Factor X Functional Test at DNA Labs UAE is set at 1100 AED, offering patients access to critical health information with state-of-the-art laboratory technology. This test is particularly recommended for individuals exhibiting symptoms of bleeding disorders or for those with a family history of such conditions, ensuring timely diagnosis and management of potential health risks.
The "Kidney Stone Formation Therapeutic Monitoring Panel Test" is a comprehensive diagnostic tool offered by DNA Labs UAE, aimed at individuals who are either prone to kidney stones or are currently managing this condition. Priced at 1100 AED, this panel test is designed to provide detailed insights into the various biochemical and physiological factors that contribute to the formation of kidney stones. By analyzing a range of markers, including mineral levels, pH balance, and other relevant indicators, the test helps in identifying the underlying causes of kidney stone formation. This information is crucial for healthcare providers to develop personalized treatment plans and dietary recommendations to prevent the recurrence of kidney stones. Conducted in a state-of-the-art facility, the test ensures accuracy and reliability, making it a valuable resource for therapeutic monitoring and management of kidney stone disease.
The Mucopolysaccharidosis (MPS) Type 1 Hurler Quantitative Blood Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect and quantify specific enzyme levels associated with MPS Type 1, also known as Hurler syndrome. MPS Type 1 is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase, leading to the accumulation of glycosaminoglycans in the body, which can affect multiple organ systems and lead to severe symptoms. This test plays a crucial role in the early diagnosis and management of the condition, allowing for timely intervention and treatment strategies to be implemented. The cost of the test is set at 1100 AED, reflecting the specialized nature of the analysis and the advanced technology utilized in the process. Conducted at DNA Labs UAE, a facility known for its state-of-the-art diagnostic services, this test is a vital tool for healthcare professionals and families seeking to understand and manage MPS Type 1 Hurler syndrome.
The SARS-CoV-2 Monitoring Panel Test is a comprehensive diagnostic tool designed to detect and monitor the presence of the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. Offered at DNA Labs UAE, this test is pivotal for individuals seeking to understand their infection status, particularly in environments where accurate and rapid diagnosis is crucial for preventing virus spread.
Costing 1100 AED, the test utilizes advanced molecular techniques to identify the virus's genetic material, ensuring high sensitivity and specificity. It is suitable for those who are symptomatic, have been in contact with a confirmed COVID-19 case, or require testing for travel, work, or peace of mind. The test is conducted in a state-of-the-art laboratory setting by professional healthcare personnel, adhering to stringent safety and quality standards.
Results from the SARS-CoV-2 Monitoring Panel Test provide critical information for individual care management and contribute to broader public health efforts in tracking and controlling COVID-19 outbreaks. With its commitment to accuracy and quick turnaround times, DNA Labs UAE plays a vital role in the ongoing fight against the pandemic, offering a reliable testing solution for the community.
The Ganglioside GD1b Antibody IgM Test is a specialized diagnostic assessment aimed at detecting the presence of IgM antibodies against the ganglioside GD1b in the blood. Gangliosides are a type of glycosphingolipid with one or more sialic acids attached to a sugar chain, and they play crucial roles in the central nervous system, including in the development and functioning of nerve cells. The presence of antibodies against ganglioside GD1b can be indicative of certain neurological conditions, such as Guillain-Barré syndrome (GBS), multifocal motor neuropathy, and other autoimmune neuropathies. These conditions often involve the immune system mistakenly attacking the body's own nerve tissues, leading to a range of neurological symptoms.
The test is conducted by collecting a blood sample from the patient, which is then analyzed for the specific IgM antibodies targeting ganglioside GD1b. A positive result may suggest an autoimmune response affecting the nervous system, aiding healthcare providers in diagnosing and managing the patient's condition more effectively.
In the United Arab Emirates, this test is available at DNA Labs UAE, a reputable laboratory known for its comprehensive range of diagnostic services. The cost of the Ganglioside GD1b Antibody IgM Test at DNA Labs UAE is 1100 AED. Patients seeking this test are usually referred by their healthcare provider based on their symptoms and clinical history, ensuring a targeted approach to diagnosing and treating neurological conditions associated with autoimmune responses.
The Adenovirus Qualitative PCR Test is a sophisticated diagnostic tool employed to detect the presence of adenovirus DNA in a patient's sample, such as blood, tissue, or respiratory secretions. Adenoviruses are a group of common viruses that can cause a range of illnesses, from mild cold-like symptoms to more severe infections like bronchitis, pneumonia, and even gastrointestinal diseases. The test utilizes Polymerase Chain Reaction (PCR) technology, a highly sensitive and specific method, to amplify small segments of the virus's DNA, making it possible to identify an infection even when the viral load is low.
This test is particularly useful in clinical settings for early diagnosis and management of adenovirus infections, especially in patients with weakened immune systems where the infection can be more severe and prolonged. Early detection allows for timely intervention, potentially improving patient outcomes.
At DNA Labs UAE, the Adenovirus Qualitative PCR Test is available for a cost of 1080 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable results. The test is conducted in a controlled environment following strict quality control measures, making DNA Labs UAE a trusted choice for diagnostic testing in the region.
The "AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test" is a specialized diagnostic procedure aimed at detecting the presence of a specific chromosomal abnormality associated with acute myeloid leukemia (AML), known as the t(8;21) translocation. This translocation results in the ETO gene on chromosome 8 being rearranged and fused with the AML1 gene on chromosome 21, which can lead to the development of leukemia by affecting normal cell growth and differentiation.
Performed at DNA Labs UAE, this test employs the Polymerase Chain Reaction (PCR) technique, a highly sensitive method for detecting specific DNA sequences, to identify the AML ETO t(8;21) gene rearrangement qualitatively. This means the test is designed to confirm the presence or absence of the gene rearrangement, rather than quantifying the amount of rearranged gene product.
The cost of the AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test is set at 1000 AED. This test is crucial for the diagnosis, prognosis, and management of patients with acute myeloid leukemia, as the presence of the t(8;21) translocation is associated with a specific subtype of AML that may respond differently to certain treatments. Identifying this genetic abnormality helps healthcare providers tailor treatment plans to improve outcomes for patients with AML.
The BCR-ABL Gene Rearrangement PCR Qualitative Test is a sophisticated diagnostic procedure designed to detect the presence of the BCR-ABL gene fusion, a significant genetic abnormality often associated with certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This rearrangement results from a translocation between chromosomes 9 and 22, creating the Philadelphia chromosome, which is a hallmark of these leukemias. The test employs Polymerase Chain Reaction (PCR) technology, a sensitive and specific method that amplifies traces of the BCR-ABL gene sequence, enabling the detection of this genetic anomaly even at very low levels.
Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the BCR-ABL Gene Rearrangement PCR Qualitative Test is crucial for the diagnosis, prognosis, and monitoring of treatment response in patients suspected of having leukemia linked to the BCR-ABL fusion gene. This test is instrumental in guiding treatment decisions, including the use of tyrosine kinase inhibitors that specifically target cells harboring this genetic abnormality.
The cost of the BCR-ABL Gene Rearrangement PCR Qualitative Test at DNA Labs UAE is set at 1000 AED. This investment is pivotal for patients requiring a definitive diagnosis of leukemia types associated with the BCR-ABL gene rearrangement, offering them a pathway to targeted treatment and potentially improved outcomes.
